Abstract: Hydrogen containing tail gas from a hydrocarbon synthesis reactor is used as a hydrogen containing catalyst rejuvenating gas. If CO is present, the CO content, is less than 10 mole % of the gas and the H.sub.2 to CO mole ratio is greater than 3:1. At least a portion of the water and liquid hydrocarbons are removed from the tail gas, before it is used to rejuvenate the reversibly deactivated catalyst.

Abstract: A process is disclosed for fabricating a thermal inkjet printhead in which the driving circuitry and heating resistors are incorporated in a single integrated circuit. In the process, a protective cavitation layer, which may contain tantalum, is deposited at the locations of the heating regions over a passivation layer and is then patterned prior to any patterning or etching of the passivation layer. A via is then formed in the passivation layer.

Abstract: The invention relates to a method for the selective hydrogenation of a dinitrile compound in the presence of a catalyst which comprises a metal of group 8 of the periodic system of the elements, the catalyst comprising a zeolite having a pore diameter of between 0.3 and 0.7 nm. The zeolite preferably has a structure chosen from the structures: ABW, AEI, AFT, ANA, ATN, ATV, ATT, AWW, BIK, CAS, CHA, DDR, EAB, EDI, ERI, GIS, JBW, KFI, LEV, LTA, MER, NAT, PHI, RHO, THO, YUG.

Abstract: Sex steroid precursors such as dehydroepiandrosterone and dehydroepiandrosterone sulphate, and compounds converted in vivo to either of the foregoing, are utilized for the treatment and/or prevention of vaginal atrophy, hypogonadism, diminished libido, osteoporosis, urinary incontinence, ovarian cancer, uterine cancer, skin atrophy, for contraception, and, in combination with an estrogen and/or progestin, for the treatment of menopause. The precursors may be formulated for percutaneous or transmucosal administration. Gels, solutions, lotions, creams, ointments and transdermal patches for the administration of these precursors are provided, as are certain pharmaceutical compositions and kits which can be used for the prevention and treatment of a wide variety of conditions related to decreased secretion of sex steroid precursors by the adrenals.

Abstract: A process for preparing N-methyl-2-(3,4-dimethoxyphenyl)-ethylamine comprises hydrogenating 3,4-dimethoxyphenylacetonitrile with a methylamine of the general formula I ##STR1## where R.sup.1 is hydrogen, benzyl or tert-butyl, and hydrogen in the presence of a supported catalyst which comprises from 0.05 to 50% by weight of copper chromite, copper, silver, gold, iron, cobalt, nickel, ruthenium, rhodium, palladium, osmium, iridium, platinum or mixtures thereof, in the presence or absence of water at from 20.degree. to 200.degree. C. under from 1 to 300 bar.

Abstract: An improvement in a process for the preparation of a p-aminodiarylamine by reduction of the corresponding nitroso or nitro compound with hydrogen in a hydrogenator in the presence of a catalyst is disclosed. The invention includes equipping the hydrogenator with filtration means capable of separating the p-aminodiarylamine product from the catalyst, whereby the p-aminodiarylamine product can be removed from the hydrogenator while the catalyst is retained therein, thereby permitting the reaction to be run semicontinuously or continuously.

Abstract: The present invention relates to the use of a group of propargylamines of the general formula (I) ##STR1## wherein R.sup.1 is hydrogen or CH.sub.3 and R.sup.2 is (CH.sub.2).sub.n CH.sub.3 and n is an integer from 0 to 16, and salts thereof, as cellular rescue agents in the treatment and prevention of diseases in which cell death occurs by apoptosis. Some of the compounds of formula I are novel. The invention is also directed to the use of these compounds in the treatment of these diseases, as well as to processes for the preparation of the compounds.

Abstract: Disclosed is a process for the preparation of a process for the separation and purification of amines from a mixed reaction crude liquid containing ethylamines prepared by a reaction of ethylalcohol or acetaldehyde with ammonia, and triethylamine can be predominantly prepared without accumulation of ingredients having intermediate boiling-points.

Abstract: 2-Trifluoromethoxy-aniline, which can be used as an intermediate for example for preparing pharmaceuticals and agrochemicals, is obtained in very good yields and high purity by nitrating in a first step 1,2-dichlorotrifluoromethoxy-benzene at temperatures between -20.degree. C. and +80.degree. C. and catalytically hydrogenating the resulting nitration products (exclusively 1,2-dichloro-5-nitro-4-trifluoromethoxy-benzene and 1,2-dichloro-3-nitro-4-trifluoromethoxy-benzene) in a 2nd step, it being possible to isolate the aniline intermediates corresponding to the two nitrobenzene derivatives; the nitrobenzene and aniline derivatives mentioned, being novel compounds, are also part of the subject matter of the invention.

Abstract: A process for preparing amines of the formula I ##STR1## where R.sup.1,R.sup.2,R.sup.3,R.sup.4,R.sup.5,R.sup.6 are hydrogen, C.sub.1 - to C.sub.20 -alkyl, C.sub.2 - to C.sub.20 -alkenyl, C.sub.2 - to C.sub.20 -alkynyl, C.sub.3 - to C.sub.20 -cycloalknyl, C.sub.4 - to C.sub.20 -alkyl-cycloalkyl, C.sub.4 - to C.sub.20 -cycloalkyl-alkyl, aryl, C.sub.7 - to C.sub.20 -alkylaryl or C.sub.7 - to C.sub.20 -aralkyl,R.sup.1 and R.sup.2 jointly are a saturated or unsaturated C.sub.3 - to C.sub.9 -alkylene divalent chain andR.sup.3 or R.sup.5 are C.sub.21 - to C.sub.200 -alkyl, C.sub.21 - to C.sub.200 -alkenyl or jointly are a C.sub.2 - to C.sub.12 -alkylene divalent chain,by reacting olefins of the formula II ##STR2## where R.sup.3, R.sup.4, R.sup.5 and R.sup.6 have the abovementioned meanings, with ammonia or primary or secondary amines of the formula III ##STR3## where R.sup.1 and R.sup.2 have abovementioned meanings, at from 200.degree. to 350.degree. C.

Abstract: The present invention relates to certain purine nucleoside analogues containing a carbocyclic ring ill place of trip sugar residue, salts, esters and pharmaceutically acceptable derivatives thereof, processes for there preparation, pharmaceutical formulations containing them, and to the use of such compounds in therapy, particularly the treatment of or prophylaxis of certain viral infections.

Abstract: An improved method for the selective oxidation of alkyl-5-valerate to monomethyl adipate (e.g., methyl-5-valerate to monomethyl adipate). By performing the air oxidation at high pressure (i.e.,>10 bars air and preferably 35 to 65 bars) and relatively moderate temperature (i.e., 20 to 120.degree. C.) in the absence of a catalyst, commercial rates of conversion can be sustained at optimum selectivity to the desired product. Such a high pressure process is particularly amenable to continuous operating the oxidation reactor at optimum selectivity at the expense of conversion per pass followed by product separation and recycle of reactants.

Abstract: A process for preparing N-alkyl-substituted aminoalkynes by reacting an alkyne with a carbonyl compound and an amine with heterogeneous catalysis in which an unsupported copper acetylide derived from malachite is used as the catalyst. The N-alkyl-substituted aminoalkyne have a wide variety of uses including their use as precursors for pharmaceuticals, their use in electroplating processes and their use as corrosion inhibitors.

Abstract: N-Hydroxyalkyl-substituted aminoalkynes of the formula I ##STR1## are prepared by reacting an alkyne with a 1-oxa-3-azaheterocyclo-alkane in a reaction with heterogeneous catalysis by a catalyst which comprises a compound of a metal of the first or second sub-group.

Abstract: The present invention relates to a process for the preparation of aromatic amines of the formula (I)Ar--NR.sup.1 R.sup.2 (I)in which Ar is ##STR1## and R.sup.3 to R.sup.9 independently of one another are hydrogen, C.sub.1 -C.sub.8 -alkyl, alkoxy-(C.sub.1 -C.sub.8), acyloxy-(C.sub.1 -C.sub.8), OAr, Ar, fluorine, chlorine, bromine, iodine, OH, NO.sub.2, CN, CO.sub.2 H, CHO, SO.sub.3 H, SO.sub.2 R, SOR, NH.sub.2, NH-alkyl-(C.sub.1 -C.sub.12), N-alkyl.sub.2 -(C.sub.1 -C.sub.12), NHCO-alkyl-(C.sub.1 -C.sub.12), CO-alkyl-(C.sub.1 -C.sub.12), NHCHO, COAr, CO.sub.2 Ar, CF.sub.3, CONH.sub.2, CHCHCO.sub.2 R, POAr.sub.2, PO-alkyl.sub.2 -(C.sub.1 -C.sub.12), 5-ring heteroaryl, 6-ring heteroaryl, Si-alkyl.sub.3 -(C.sub.1 -C.sub.12), where R=alkyl(C.sub.1 -C.sub.8), aryl(C.sub.5 -C.sub.10) and R.sup.1 and R.sup.2 independently of one another are hydrogen, C.sub.1 -C.sub.

Abstract: The invention provides a novel sulfonium salt having at least one acid labile group attached to a phenyl group in a molecule and a C.sub.2 -C.sub.20 alkylsulfonate or arylsulfonate anion whose alkyl or aryl has as a substituent an electron withdrawing group such as fluorine and nitro group. The novel sulfonium salt is effective for increasing the dissolution contrast between exposed and unexposed areas. Upon exposure, it generates a substituted alkyl or arylsulfonic acid which is a weak acid, minimizing the influence of side reaction and deactivation during PEB step. The sulfonium salt is useful in a chemically amplified positive resist composition which lends itself to fine patterning and features high resolution.

Abstract: The present invention relates to liquid herbicidal agents in the form of emulsifiable concentrates (EC) or concentrated emulsions (EW), which, in addition to 1-40% by weight of the active compound diclofop-methyl (I), fenoxaprop-ethyl (II) or the optically active isomer (D+) thereof fenoxaprop-P-ethyl (III), contain, as surfactants, 0.5-30% by weight of (C.sub.10 -C.sub.18)-fatty alcohol polyglycol ethers or (C.sub.8 -C.sub.9)-alkylphenyl polyglycol ethers which are ethoxylated with 6-10 mol of ethylene oxide, and in the case of EC formulations 0.5-7% by weight of calcium (C.sub.8 -C.sub.14)-alkylbenzenesulfonate, and in the case of EW formulations, as a dispersing agent, 0.5-7% by weight of an ethylene oxide-propylene oxide-ethylene oxide block copolymer phosphorylated in the alpha- and omega-position, or a salt thereof, in addition to the customary formulation constituents.

Abstract: Alkyl-substituted polyarenes of the formula ##STR1## in which R is alkyl and Ar.sub.res is an aryl residue, are prepared from aryl ketones by reaction of the latter with 1-cyclohexenyloxytrimethylsilane in the presence of a Friedel-Crafts catalyst. When R is methyl and Ar.sub.res is a naphthyl residue, the reaction serves as a step in a reaction scheme leading to crisnatol mesylate, a pharmaceutical useful in the treatment of brain cancer.

Abstract: Aliphatic hydrocarbyl-substituted aromatic amines are prepared by reacting an aromatic amine and an aliphatic hydrocarbylating agent, such as an olefin, in the presence of a heteropolyacid catalyst such as Cs.sub.2.5 H.sub.0.5 PW.sub.12 O.sub.40, for a period of time and at a temperature sufficient to permit reaction.

Abstract: A process of preparing an organic amine having at least one unsaturated group, such as an arylamine, involving contacting an unsaturated organic sulfonate, such as an aryl sulfonate, with a reactant amine, such as an alkyl or aryl amine, in the presence of a base and a transition metal catalyst under reaction conditions. The transition metal catalyst contains a Group 8 metal and a chelating ligand, for example a Group 15-substituted arylene or Group 15-substituted metallocene, such as 1,1'-bis(diphenylphosphino)-2,2'-binaphthyl or 1,1'-bis(diphenylphosphino)-ferrocene, respectively. The aryl sulfonate can be prepared from a phenol and sulfonating agent.